Novel stool-based protein biomarkers for improved colorectal cancer screening: A case–control study
Annals of Internal Medicine Nov 29, 2017
Bosch LJW, et al. - The purpose of this research was to determine novel protein biomarkers in stool that outperform or complement hemoglobin in detecting colorectal cancer (CRC) and advanced adenomas. The novel candidate protein biomarkers for CRC screening were detected via mass spectrometry of stool samples. It was discovered that several protein combinations outperformed hemoglobin in discriminating CRC or advanced adenoma from control samples. Proof of concept that such proteins could be detected with antibody-based assays in small sample volumes pointed towards the ability of these biomarkers to be applied in population screening.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries